ELI LILLY GLOBAL HEADQUARTERS

DIGITAL ASSET DESCRIPTION The RWA tied to 893 S. Delaware Street, Indianapolis, IN 46285 represents ownership exposure to the global headquarters of Eli Lilly and Company, one of the largest and most influential pharmaceutical companies in the world. From this location, corporate leadership oversees research, development, manufacturing, and business operations that support the creation of medicines used by millions of people across the globe. What makes this asset significant is its connection to an institution that has played a major role in modern healthcare for more than a century. Eli Lilly has been responsible for advancements in diabetes treatment, oncology, neuroscience, immunology, and other critical areas of medicine. The company has helped shape the pharmaceutical industry while contributing to some of the most important healthcare innovations of the modern era. The blockchain connection is direct. Pharmaceutical companies develop and deliver products that create real-world value, while blockchain networks provide verifiable systems for recording ownership and preserving provenance. Both serve as infrastructure supporting trust, accountability, and long-term value creation. As a blockchain-based real-world asset, 893 S. Delaware Street represents verifiable exposure to one of America's most important healthcare institutions and a company whose work has influenced medicine, public health, and scientific advancement around the world. The significance of this address is not the headquarters building itself. The significance is that it serves as the command center of a pharmaceutical institution whose discoveries, medicines, and innovations have impacted millions of lives across generations. ## Archived & Preserved by Jacob Alan Ervin Lovaas🇺🇸🎩 June 6, 2026